Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Regulatory News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Advanced Oncotherapy - Minmetco Limited

12 May 2023 12:53

RNS Number : 2885Z
Advanced Oncotherapy PLC
12 May 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Minmetco Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Advanced Oncotherapy PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12 May 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Advanced Oncotherapy PLC ordinary shares

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,200,000

1.15

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

6,200,000

1.15

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Warrants to subscribe for ordinary shares

Details, including nature of the rights concerned and relevant percentages:

5,000,000 warrants at 60p expiring on 28 February 2025 and 1,200,000 warrants at 25p expiring on 1 July 2026

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

NO

 

 

Date of disclosure:

12 May 2023

Contact name:

Fotini Kaimaklioti

Telephone number*:

00357 25 557703

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETATMBTMTABBTJ
Date   Source Headline
25th Jul 201411:39 amRNSResult of AGM
25th Jul 20147:00 amRNSAGM Statement
22nd Jul 20147:00 amRNSNew Contract Signed with ScandiNova
16th Jul 201410:59 amRNSChange of Adviser
14th Jul 20147:00 amRNSContract Signed with global IT leader ICT
30th Jun 20141:16 pmRNSSector Reclassification
30th Jun 20147:00 amRNSFinal Results
23rd Jun 20147:00 amRNSAdvanced Oncotherapy Announce New American Entity
4th Jun 201411:19 amRNSHolding(s) in Company
2nd Jun 20147:00 amRNSAppointment of New CEO
20th May 20147:00 amRNSAVO features in CNY Business Journal
30th Apr 20147:01 amRNSDirector deals and Share Option Scheme
28th Apr 20147:00 amRNSAppointment of Director of Project Planning
17th Apr 201410:41 amRNSPLacing and Subscription
25th Mar 20147:00 amRNSConversion of Loan
10th Mar 20147:00 amRNSPresenting at National Proton Conference
20th Feb 20147:00 amRNSNew Board Appointment
6th Feb 20147:01 amRNSNew Medical Advisory Board Appointment
16th Jan 20147:00 amRNSChange of Nomad and Broker
9th Jan 20148:58 amRNSIssue of Equity
4th Dec 20137:00 amRNSCollider Exhibition at Science Museum
26th Nov 20137:00 amRNSAppointment of Bob Rose
22nd Nov 20137:00 amRNSAppointment of Executive Director
6th Nov 201312:08 pmRNSIssue of Equity
31st Oct 20137:00 amRNSDr Jay Loeffler Joins Medical Advisory Board
25th Oct 20137:00 amRNSBoard Changes
3rd Oct 20137:00 amRNSAppointment to Advisory Board and Issue of Equity
1st Oct 20137:00 amRNSAppointment of Director, Issue of Equity
25th Sep 20137:01 amRNSHalf Yearly Report
25th Sep 20137:00 amRNSAcquisition
18th Sep 20137:00 amRNSCollaboration Agreement
30th Aug 20137:15 amRNSDirectorate Change
23rd Aug 201312:14 pmRNSDirectorate Change
20th Aug 20137:00 amRNSCollaboration with Spire Healthcare
26th Jul 201312:17 pmRNSReplacement: Result of AGM
25th Jul 20135:37 pmRNSResult of AGM
19th Jul 201312:18 pmRNSHolding(s) in Company
10th Jul 20137:00 amRNSIssue of Equity
28th Jun 201312:23 pmRNSFinal Results
27th Jun 20137:00 amRNSIssue of Equity
4th Jun 201310:03 amRNSResult of Meeting
3rd Jun 20137:00 amRNSCollaboration with BMI Healthcare
16th May 20137:00 amRNSPosting of Circular
3rd May 20137:00 amRNSDirector Appointment
30th Apr 20137:00 amRNSHolding(s) in Company
26th Apr 201312:21 pmRNSDirector Dealing
26th Apr 20137:00 amRNSDirector Appointment
26th Apr 20137:00 amRNSDirector Dealing
25th Apr 20134:28 pmRNSHolding(s) in Company
25th Apr 20139:34 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.